Search Results - "JONES, PAUL W."

Minimal Clinically Important Differences in Pharmacological Trials by JONES, Paul W, BEEH, Kai M, CHAPMAN, Kenneth R, DECRAMER, Marc, MAHLER, Donald A, WEDZICHA, Jadwiga A

“…The concept of a minimal clinically important difference (MCID) is well established. Here, we review the evidence base and methods used to define MCIDs as well…”
Get full text

Tests of the Responsiveness of the COPD Assessment Test Following Acute Exacerbation and Pulmonary Rehabilitation by Jones, Paul W., PhD, Harding, Gale, MA, Wiklund, Ingela, PhD, Berry, Pamela, MSc, Tabberer, Maggie, MSc, Yu, Ren, MA, Leidy, Nancy K., PhD

“…Background The COPD Assessment Test (CAT) is an eight-item questionnaire suitable for routine clinical use that shows reliability and validity in stable and…”
Get full text

Development and Validation of an Improved, COPD-Specific Version of the St. George Respiratory Questionnaire by Meguro, Makiko, Barley, Elizabeth A, Spencer, Sally, Jones, Paul W

“…To produce an improved, COPD-specific version of the St. George respiratory questionnaire (SGRQ-C). Five different steps were required: (1) Rasch analysis of…”
Get more information

Efficacy and safety of twice-daily aclidinium bromide in COPD patients: the ATTAIN study by JONES, Paul W, SINGH, Dave, BATEMAN, Eric D, AGUSTI, Alvar, LAMARCA, Rosa, DE MIQUEL, Gonzalo, SEGARRA, Rosa, CARACTA, Cynthia, GARCIA GIL, Esther

“…The efficacy and safety of two doses of aclidinium bromide were evaluated in patients with moderate to severe chronic obstructive pulmonary disease (COPD). In…”
Get full text

Efficacy of umeclidinium/vilanterol versus umeclidinium and salmeterol monotherapies in symptomatic patients with COPD not receiving inhaled corticosteroids: the EMAX randomised trial by Maltais, François, Bjermer, Leif, Kerwin, Edward M, Jones, Paul W, Watkins, Michael L, Tombs, Lee, Naya, Ian P, Boucot, Isabelle H, Lipson, David A, Compton, Chris, Vahdati-Bolouri, Mitra, Vogelmeier, Claus F

“…Prospective evidence is lacking regarding incremental benefits of long-acting dual- versus mono-bronchodilation in improving symptoms and preventing short-term…”
Get full text

Usefulness of the Chronic Obstructive Pulmonary Disease Assessment Test to Evaluate Severity of COPD Exacerbations by MACKAY, Alex J, DONALDSON, Gavin C, PATEL, Anant R. C, JONES, Paul W, HURST, John R, WEDZICHA, Jadwiga A

“…The Chronic Obstructive Pulmonary Disease (COPD) Assessment Test (CAT) is an eight-item questionnaire designed to assess and quantify the impact of COPD…”
Get full text

Salmeterol and Fluticasone Propionate and Survival in Chronic Obstructive Pulmonary Disease by Calverley, Peter M.A, Anderson, Julie A, Celli, Bartolome, Ferguson, Gary T, Jenkins, Christine, Jones, Paul W, Yates, Julie C, Vestbo, Jørgen

“…This trial involving more than 6000 patients with chronic obstructive pulmonary disease (COPD) compared the effects on all-cause mortality of treatment with an…”
Get full text

Survival After Shock Therapy in Implantable Cardioverter-Defibrillator and Cardiac Resynchronization Therapy-Defibrillator Recipients According to Rhythm Shocked by Powell, Brian D., MD, Saxon, Leslie A., MD, Boehmer, John P., MD, Day, John D., MD, Gilliam, F. Roosevelt, MD, Heidenreich, Paul A., MD, MS, Jones, Paul W., MS, Rousseau, Matthew J., MS, Hayes, David L., MD

“…Objectives This study sought to determine if the risk of mortality associated with inappropriate implantable cardioverter-defibrillator (ICD) shocks is due to…”
Get full text

Creating scenarios of the impact of COPD and their relationship to COPD Assessment Test (CAT™) scores by Jones, Paul W, Tabberer, Margaret, Chen, Wen-Hung

“…The COPD Assessment Test (CAT™) is a new short health status measure for routine use. New questionnaires require reference points so that users can understand…”
Get full text

Cardiac resynchronization therapy and the relationship of percent biventricular pacing to symptoms and survival by Hayes, David L., MD, FHRS, Boehmer, John P., MD, Day, John D., MD, FHRS, Gilliam, F.R., MD, FHRS, Heidenreich, Paul A., MD, Seth, Milan, MS, Jones, Paul W., MS, Saxon, Leslie A., MD, FHRS

“…Background With the advent of cardiac resynchronization therapy, it was unclear what percentage of biventricular pacing would be required to obtain maximal…”
Get full text

An Official American Thoracic Society/European Respiratory Society Statement: Research questions in chronic obstructive pulmonary disease by Celli, Bartolome R, Decramer, Marc, Wedzicha, Jadwiga A, Wilson, Kevin C, Agustí, Alvar, Criner, Gerard J, MacNee, William, Make, Barry J, Rennard, Stephen I, Stockley, Robert A, Vogelmeier, Claus, Anzueto, Antonio, Au, David H, Barnes, Peter J, Burgel, Pierre-Regis, Calverley, Peter M, Casanova, Ciro, Clini, Enrico M, Cooper, Christopher B, Coxson, Harvey O, Dusser, Daniel J, Fabbri, Leonardo M, Fahy, Bonnie, Ferguson, Gary T, Fisher, Andrew, Fletcher, Monica J, Hayot, Maurice, Hurst, John R, Jones, Paul W, Mahler, Donald A, Maltais, François, Mannino, David M, Martinez, Fernando J, Miravitlles, Marc, Meek, Paula M, Papi, Alberto, Rabe, Klaus F, Roche, Nicolas, Sciurba, Frank C, Sethi, Sanjay, Siafakas, Nikos, Sin, Don D, Soriano, Joan B, Stoller, James K, Tashkin, Donald P, Troosters, Thierry, Verleden, Geert M, Verschakelen, Johny, Vestbo, Jorgen, Walsh, John W, Washko, George R, Wise, Robert A, Wouters, Emiel F M, ZuWallack, Richard L

“…Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity, mortality, and resource use worldwide. The goal of this Official American…”
Get full text

Risk Factors and Temporal Trends of Complications Associated With Transvenous Implantable Cardiac Defibrillator Leads by Koneru, Jayanthi N., Jones, Paul W., Hammill, Eric F., Wold, Nicholas, Ellenbogen, Kenneth A.

“…Background The transvenous implantable cardioverter‐defibrillator (ICD) lead is the most common source of complications in a traditional ICD system. This…”
Get full text

Cognitive Dysfunction in Patients Hospitalized With Acute Exacerbation of COPD by Dodd, James W., MBChB, Charlton, Rebecca A., PhD, van den Broek, Martin D., PhD, Jones, Paul W., PhD

“…Background Cognitive impairment is one of the least well-studied COPD comorbidities. It is known to occur in hypoxemic patients, but its presence during acute…”
Get full text

GOLD 2011 disease severity classification in COPDGene: a prospective cohort study by Han, MeiLan K, Dr, Muellerova, Hana, PhD, Curran-Everett, Douglas, Prof, Dransfield, Mark T, MD, Washko, George R, MD, Regan, Elizabeth A, MD, Bowler, Russell P, MD, Beaty, Terri H, Prof, Hokanson, John E, Prof, Lynch, David A, Prof, Jones, Paul W, Prof, Anzueto, Antonio, Prof, Martinez, Fernando J, Prof, Crapo, James D, Prof, Silverman, Edwin K, MD, Make, Barry J, Prof

“…Summary Background The 2011 GOLD (Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease [COPD]) consensus…”
Get full text

Once-daily inhaled fluticasone furoate and vilanterol versus vilanterol only for prevention of exacerbations of COPD: two replicate double-blind, parallel-group, randomised controlled trials by Dransfield, Mark T, MD, Bourbeau, Jean, MD, Jones, Paul W, Prof, Hanania, Nicola A, MD, Mahler, Donald A, Prof, Vestbo, Jørgen, Prof, Wachtel, Andrew, MD, Martinez, Fernando J, MD, Barnhart, Frank, DVM, Sanford, Lisa, MSc, Lettis, Sally, PhD, Crim, Courtney, MD, Calverley, Peter MA, Prof

“…Summary Background Whether the combination of a once-daily inhaled corticosteroid with a once-daily longacting β2 agonist is more protective than a once-daily…”
Get full text

Long-term outcomes following first short-term clinically important deterioration in COPD by Naya, Ian P, Tombs, Lee, Muellerova, Hana, Compton, Christopher, Jones, Paul W

“…Chronic obstructive pulmonary disease (COPD) is characterized by varying trajectories of decline. Information regarding the prognostic value of preventing…”
Get full text

Factors affecting brain structure in smoking-related diseases: Chronic Obstructive Pulmonary Disease (COPD) and coronary artery disease by Spilling, Catherine A, Dhillon, Mohani-Preet K, Burrage, Daniel R, Ruickbie, Sachelle, Baker, Emma H, Barrick, Thomas R, Jones, Paul W

“…Changes in brain structure and cognitive decline occur in Chronic Obstructive Pulmonary Disease (COPD). They also occur with smoking and coronary artery…”
Get full text

Measuring disease activity in COPD: is clinically important deterioration the answer? by Singh, Dave, Criner, Gerard J, Naya, Ian, Jones, Paul W, Tombs, Lee, Lipson, David A, Han, MeiLan K

“…Given the heterogeneity of chronic obstructive pulmonary disease (COPD), personalized clinical management is key to optimizing patient outcomes. Important…”
Get full text

Depression: a characteristic comorbidity of COPD? by Jones, Paul W

Get full text

Comparison between an alternative and the classic definition of chronic bronchitis in COPDGene by Kim, Victor, Crapo, James, Zhao, Huaqing, Jones, Paul W, Silverman, Edwin K, Comellas, Alejandro, Make, Barry J, Criner, Gerard J

“…Previous studies on chronic bronchitis (CB) have used varying definitions. We sought to compare an alternative CB definition, using the St. George's…”
Get full text